Eptinezumab for preventing migraine

Equality Impact Assessment (Guidance development) (PDF 158 KB)

Final draft guidance

Final appraisal document (PDF 166 KB)

Committee papers (PDF 4.65 MB)

Final scope (PDF 190 KB)

Equality impact assessment (Scoping) (PDF 122 KB)

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 350 KB)

Final stakeholder list (PDF 158 KB)

Draft scope post referral (PDF 206 KB)

Draft matrix post referral (PDF 158 KB)